Reviewing Tenon Medical (NASDAQ:TNON) and Daxor (NASDAQ:DXR)

Tenon Medical (NASDAQ:TNON) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

Analyst Ratings

This is a summary of current ratings for Tenon Medical and Daxor, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	0	0	3	0	3.00
Daxor	0	0	1	0	3.00

Tenon Medical presently has a consensus target price of $4.67, suggesting a potential upside of 320.42%. Daxor has a consensus target price of $25.00, suggesting a potential upside of 210.56%. Given Tenon Medical’s higher possible upside, equities research analysts plainly believe Tenon Medical is more favorable than Daxor.

Risk & Volatility

Tenon Medical has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Comparatively, Daxor has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500.

Institutional and Insider Ownership

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 4.7% of Tenon Medical shares are owned by company insiders. Comparatively, 59.0% of Daxor shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Tenon Medical and Daxor”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.28 million	2.10	-$15.58 million	($27.23)	-0.04
Daxor	$2.13 million	18.27	N/A	N/A	N/A

Daxor has lower revenue, but higher earnings than Tenon Medical.

Profitability

This table compares Tenon Medical and Daxor’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-413.88%	-1,785.88%	-164.26%
Daxor	N/A	N/A	N/A

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.